Both in Biotechnology
Voyager Therapeutics vs Outlook Therapeutics
Over the past year VYGR returned −60.1% and OTLK returned −64.6%; their daily moves had a correlation of 0.09.
VYGR −60.1% OTLK −64.6%Growth of $1, one year, split-adjusted
| Metric | VYGR | OTLK |
|---|---|---|
| Price | $1.83 | $0.4600 |
| Market cap | $112.8M | $112.0M |
| Today | +2.81% | −1.96% |
| 1 month | −25.6% | −22.8% |
| 6 months | −53.1% | +90.3% |
| Year to date | −53.4% | −70.9% |
| 1 year | −60.8% | −63.5% |
| Revenue growth (YoY) | −39.1% | −99.4% |
| Gross margin | 100.0% | −95.0% |
| Net margin | −773.2% | −233554.9% |
| P/E (TTM) | — | — |
| Price / sales | 3.3× | — |
| Net cash | $116.3M | -$7.0M |
| Dividend yield | — | — |
| Volatility (60d) | 60.9% | 89.0% |
| Short % of float | 7.8% | 39.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).